Immunoendocrinology of the Thymus in Chagas Disease


Autoria(s): PEREZ, Ana Rosa; SILVA-BARBOSA, Suse Dayse; ROGGERO, Eduardo; CALMON-HAMATY, Flavia; VILLAR, Silvina R.; GUTIERREZ, Fredy R.; SILVA, Joao Santana; SAVINO, Wilson; BOTTASSO, Oscar
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

During immune response to infectious agents, the host develops an inflammatory response which could fail to eliminate the pathogen or may become dysregulated. In this case, the ongoing response acquires a new status and turns out to be detrimental. The same elements taking part in the establishment and regulation of the inflammatory response (cytokines, chemokines, regulatory T cells and counteracting compounds like glucocorticoids) may also mediate harmful effects. Thymic disturbances seen during Trypanosoma cruzi (T. cruzi) infection fit well with this conceptual framework. After infection, this organ suffers a severe atrophy due to apoptosis-induced thymocyte exhaustion, mainly affecting the immature double-positive (DP) CD4+CD8+ population. Thymus cellularity depletion, which occurs in the absence of main immunological mediators involved in anti-T. cruzi defense, seems to be linked to a systemic cytokine/hormonal imbalance, involving a dysregulated increase in Tumor Necrosis Factor alpha (TNF-alpha) and corticosterone hormone levels. Additionally, we have found an anomalous exit of potentially autoimmune DP cells to the periphery, in parallel to a shrinkage in the compartment of natural regulatory T cells. In this context, our data clearly point to the view that the thymus is a target organ of T. cruzi infection. Preserved thymus may be essential for the development of an effective immune response against T. cruzi, but this organ is severely affected by a dysregulated circuit of proinflammatory cytokines and glucocorticoids. Also, the alterations observed in the DP population might have potential implications for the autoimmune component of human Chagas disease. Copyright (C) 2011 S. Karger AG, Basel

CONICET, Argentina[PIP-CONICET 0789]

FONCYT, Argentina[PICT 2008-0980]

SeCyT-UNR, Argentina[MED 244]

SeCyT-UNR, Argentina[MED 245]

CNPq, Brazil

Faperj, Brazil

Oswaldo Cruz Foundation, Brazil

Identificador

NEUROIMMUNOMODULATION, v.18, n.5, p.328-338, 2011

1021-7401

http://producao.usp.br/handle/BDPI/23742

10.1159/000329494

http://dx.doi.org/10.1159/000329494

Idioma(s)

eng

Publicador

KARGER

Relação

Neuroimmunomodulation

Direitos

closedAccess

Copyright KARGER

Palavras-Chave #Chagas disease #Thymus atrophy #TNF-alpha #Glucocorticoids #Regulatory T cells #TRYPANOSOMA-CRUZI INFECTION #TUMOR-NECROSIS-FACTOR #PITUITARY-ADRENAL AXIS #REGULATORY T-CELLS #IMMUNE-SYSTEM #TNF-ALPHA #EXTRACELLULAR-MATRIX #THYMOCYTE SELECTION #GAMMA-INTERFERON #NITRIC-OXIDE #Endocrinology & Metabolism #Immunology #Neurosciences
Tipo

article

original article

publishedVersion